this post was submitted on 23 Jun 2023
70 points (100.0% liked)
News
7 readers
5 users here now
Breaking news and current events worldwide.
founded 2 years ago
you are viewing a single comment's thread
view the rest of the comments
view the rest of the comments
The rise of metabolic syndromes is probably going to continue to define the next 50 years of medicine honestly. We have a huge, global rise in T2DM, obesity, high cholesterol/BP/etc. due to many things, but primarily the American, carb rich diet and a sedentary lifestyle. That said, i'm hopeful. We've got lots of new treatments for diabetes and even obesity now with GLP1s(Ozempic and others), as well as efforts to make insulins, glucose monitoring devices, etc. cheaper and more available. This makes diabetes so much easier to manage compared to how it used to be. I really hope Ozempic/Wegovy et. al will help put a dent in obesity, because that's probably the biggest risk factor for all the nasty stuff down the line.
Physician here. I completely agree. I have seen quite a few changes and additions to therapy for DM in the last 20 years of my career. Thankfully, most of these have shown a continual decrease in the likelihood of heart attack and stroke associated with DM. As you say, the GLP1s are a miracle and offer very convenient dosing (in some cases weekly).